Literature DB >> 18316438

Psychotic symptoms following buprenorphine withdrawal.

Laurent Karila, Ivan Berlin, Amine Benyamina, Michel Reynaud.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316438     DOI: 10.1176/appi.ajp.2007.07071103

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

Review 1.  New-Onset Psychotic Symptoms Following Abrupt Buprenorphine/Naloxone Discontinuation in a Female Patient with Bipolar Disorder: A Case Report.

Authors:  Yezhe Lin; Alexander D Zhang; Ching-Fang Sun; Justin B White; Ansi Qi; Jessica A Farrell; Robert L Trestman; Rachel K Martin; Anita S Kablinger
Journal:  Psychopharmacol Bull       Date:  2022-06-27

2.  Receptor-Mediated AKT/PI3K Signalling and Behavioural Alterations in Zebrafish Larvae Reveal Association between Schizophrenia and Opioid Use Disorder.

Authors:  Siroshini K Thiagarajan; Siew Ying Mok; Satoshi Ogawa; Ishwar S Parhar; Pek Yee Tang
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

3.  Experience of the use of Ketamine to manage opioid withdrawal in an addicted woman: a case report.

Authors:  Laurence Lalanne; Chloe Nicot; Jean-Philippe Lang; Gilles Bertschy; Eric Salvat
Journal:  BMC Psychiatry       Date:  2016-11-10       Impact factor: 3.630

4.  Psychotic Symptoms in Heroin Withdrawal: A Case Report.

Authors:  Surabhi Sharma; Prerak Kumar; Romil Singh; Guneet S Sidhu; Kaushal Shah
Journal:  Cureus       Date:  2021-01-11

5.  An Engineered Endomorphin-2 Gene for Morphine Withdrawal Syndrome.

Authors:  Fei-Xiang Wu; Yan He; Hui-Ting Di; Yu-Ming Sun; Rui-Rui Pan; Wei-Feng Yu; Renyu Liu
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

6.  The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance.

Authors:  Angelo G I Maremmani; Alessandro Pallucchini; Luca Rovai; Silvia Bacciardi; Vincenza Spera; Marco Maiello; Giulio Perugi; Icro Maremmani
Journal:  Ann Gen Psychiatry       Date:  2018-04-18       Impact factor: 3.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.